Prestige Consumer Healthcare Inc. · NYSE:PBH
Prestige Consumer Healthcare — Q2 FY2021 Earnings Presentation
23 slides from Prestige Consumer Healthcare's earnings presentation, Nov 5, 2020
Slide 1: Second Quarter FY 2021 Results
Exhibit 99.2 Second Quarter FY 2021 Results November 5th, 2020
Slide 2: Safe Harbor Disclosure
Safe Harbor Disclosure This presentation contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company’s expected financial performance, including revenues, EPS, and free cash flow; the Company’s abi
Slide 3: Agenda for Today's Discussion
Agenda for Today’s Discussion I. Strategic Priorities II. Financial Overview III. Performance Highlights IV.FY 21 Outlook SECOND QUARTER FY 21 RESULTS 3
Slide 4: I. Strategic Priorities
I. Strategic Priorities SECOND QUARTER FY 21 RESULTS
Slide 5: Strategy in Place for Value Creation
Strategy in Place for Value Creation Brand-Building designed to grow categories and connect with consumers Long-Term Strategy Strategy and tactics performing well in disrupted environment Continuity plans continue to protect service levels Business Continuity Investing in inventory has paid
Slide 6: II. Financial Overview
II. Financial Overview SECOND QUARTER FY 21 RESULTS
Slide 7: Key Financial Results for Second Quarter and 1H FY Performance
Key Financial Results for Second Quarter and 1H FY 21 Performance FY 21 FY 20 Revenue of $237.4 million, down slightly vs. PY (0.3%) (1) on an organic basis 4.6% $237.4 $238.1 14.7% Q2 $80.7 $77.1 $0.78 $0.68 (3) (3) Revenue Adjusted EBITDA Adjusted EPS Adjusted EBITDA(3) of $80.7 up 5% versus PY (0
Slide 8: FY Second Quarter and 1H Consolidated Financial Summary
FY 21 Second Quarter and 1H Consolidated Financial Summary 3 Months Ended 6 Months Ended 1H Comments Organic Revenue(1) down slightly vs. PY – Broad & diverse portfolio offset consumption headwinds in COVID-19 disrupted categories – Triple-digit eCommerce consumption growth as consumers continue t
Slide 9: Industry Leading Free Cash Flow Trends
Industry Leading Free Cash Flow Trends Free Cash Flow(3) Comments Q2 FY 21 Q2 FY 20 1H FY 21 1H FY 20 Total 1H FY 21 Free Cash Flow of $115.7 million up 18.0% vs. PY 18.0% – Q2 Free Cash Flow down slightly vs. PY due to CapEx timing, as expected $115.7 (3) $98.0 Net Debt at September 30 of $1.5
Slide 10: III. Performance Highlights
III. Performance Highlights SECOND QUARTER FY 21 RESULTS
Slide 11: Pandemic Efforts Enabling Strong Performance
Pandemic Efforts Enabling Strong Performance Workforce Supply Base Service Prioritize health & Working closely with Continued focus safety while staffing suppliers in dynamic on service to appropriately environment retailers SECOND QUARTER FY 21 RESULTS 11
Slide 12: Diverse Portfolio Positioned To Benefit From Changing Environment
Diverse Portfolio Positioned To Benefit From Changing Environment Total Sales by Category Consumers Seeking Trusted Brands Oral Care Women’s Dermatologicals 10% Health 10% Increased consumer focus on self-care and hygiene 26% Cough / Cold 11% Accelerated trend towards shopping online 12% Eye & Ear C
Slide 13: Winning in Consumer Shift to Online
Winning in Consumer Shift to Online eCommerce as a % Retail Sales Online Tools Increase Consumer +122% Conversion Growing eCommerce trend continued into Q2 Consumers Continue to – Robust growth across all eCommerce partners Seek Treat at Long-term focus and heavy investment on Home eCommerce cha
Slide 14: Prestige Adapting to Win in Real-Time
Prestige Adapting to Win in Real-Time Active Wash Date Night An “Amazon’s Choice” Simply Sensitive Engaging customers through campaigns both in-store and online Consumer brand promise: Brighter, whiter, and more comfortable Investment in current initiatives leading to strong momentum New cam
Slide 15: IV. FY Outlook
IV. FY 21 Outlook SECOND QUARTER FY 21 RESULTS
Slide 16: Outlook: Staying the Strategic Course to Create Value
Outlook: Staying the Strategic Course to Create Value Business and strategy remain well-positioned in changing environment Market share solid and growing during pandemic environment Top Line Trends Anticipate FY 21 Reported Revenue of ~$925 million — Expect similar dollar performance to 1H; co
Slide 17: Q&A
Q&A SECOND QUARTER FY 21 RESULTS
Slide 18: Appendix
Appendix (1) Organic Revenue is a Non-GAAP financial measure and is reconciled to the most closely related GAAP financial measure in the attached Reconciliation Schedules and / or our earnings release dated November 5, 2020 in the “About Non-GAAP Financial Measures” section. (2) Total company consum
Slide 19: Reconciliation Schedules
Reconciliation Schedules Organic Revenue Change Three Months Ended September 30, Six Months Ended September 30, 2020 2019 2020 2019 (In Thousands) GAAP Total Revenues $ 237,422 $ 238,069 $ 466,816 $ 470,223 Revenue Change (0.3%) (0.7%) Adjustments: Impact of foreign currency exchange rates - 624 - (
Slide 20: Reconciliation Schedules (Continued)
Reconciliation Schedules (Continued) Adjusted EBITDA Margin Three Months Ended September 30, Six Months Ended September 30, 2020 2019 2020 2019 (In Thousands) GAAP Net Income $ 44,589 $ 33,252 $ 88,295 $ 67,177 Interest expense, net 21,266 24,477 43,207 49,497 Provision for income taxes 7,307 10,760
Slide 21: Reconciliation Schedules (Continued)
Reconciliation Schedules (Continued) Adjusted Net Income & Adjusted EPS Three Months Ended September 30, Six Months Ended September 30, 2020 2019 2020 2019 Net Net Net Net Income EPS Income EPS Income EPS Income EPS (In Thousands, except per share data) GAAP Net Income $ 44,589 $ 0.88 $ 33,252 $ 0.6
Slide 22: Reconciliation Schedules (Continued)
Reconciliation Schedules (Continued) Adjusted Free Cash Flow Three Months Ended September 30, Six Months Ended September 30, 2020 2019 2020 2019 (In Thousands) GAAP Net Income $ 44,589 $ 33,252 $ 88,295 $ 67,177 Adjustments: Adjustments to reconcile net income to net cash provided by operating activ
Slide 23: Reconciliation Schedules (Continued)
Reconciliation Schedules (Continued) Projected EPS Projected FY'21 GAAP EPS $ 3.28 Adjustments: Normalized tax rate adjustment for discrete income tax items (a) (0.10) Total Adjustments (0.10) Projected Non-GAAP Adjusted EPS $ 3.18 a) Income tax adjustment to adjust for discrete income tax items. Pr
Prestige Consumer Healthcare — Q2 FY2021 Earnings Presentation on 6ix